“The compound SR-17018 is the initial biased agonist from the mu opioid receptor that does not result in tolerance with Persistent use,” states Stahl, a senior employees scientist while in the Bohn lab. “This can be a appealing characteristic for possible use while in the context of Continual, extreme suffering.” HealingEnergy14 ment